Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. The research is at a very early stage and it may take years before the drug could be submitted for approval. http://phx.corporate-ir.net/phoenix.zhtml?c=185399&p=irol-news&nyo=0. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director: X: 10% Owner: Officer (give title below) Other (specify below) 3. Enter Ticker : Having difficulties locating your security? SIRTRIS PHARMACEUTICALS, INC. April 15, 2005. via: Sirtris Sirtris Pharmaceuticals Inc., a biopharmaceutical company engaged in developing small molecule drugs that target the sirtuins, a recently discovered family of seven enzymes associated with the aging process, was acquired by GlaxoSmithKline (NYSE: GSK) in June of 2008 and now operates as the company’s wholly-owned subsidiary. Should the company establish a proposed alliance with a pharmaceutical firm? Sirtris Pharmaceuticals develops small molecule drugs for the treatment of aging and metabolic diseases. Christoph Westphal Resigns as Sirtris Pharmaceuticals CEO, Takes Over GlaxoSmithKline's SR One Venture Arm. Energesis Pharmaceuticals, Co-Founded by Sirtris Pharmaceuticals Veteran, Seeks to Tap Power of "Good Fat" in Fighting Obesity and Diabetes. This is the Cambridge home of two-year-old Sirtris Pharmaceuticals. Sirtris Pharmaceuticals is funded by 10 investors. 2021 It will trade on the Nasdaq under ticker symbol SIRT, while JPMorgan served as lead underwriter. Profile More Content. Sirtris Pharma: SRT501 Data Is From Pre-Clinical Models. Ticker ZEN - was ticker for Zeneca before it became AstraZeneca. Any idea when, The news with SIRT just keeps getting better, And, especially with the baby boomer generation reaching, Especially since many of the current drugs used, With Type 2 Diabetes and Obesity having reached, Positive trial results picked up all over the, "SIRT1 transgenic mice show phenotypes resembling calorie restriction.Bordone, SIRT on NIGHTLINE,RIGHT NOW..............I need a drink of. All arguments should be logically sound and supported by evidence from the case whenever possible. The stock market hasn't been kind to Sirtris, which was trading at $12, down 45% … Sirtris is the most high-profile shop working on sirtuins and resveratrol-like pharmacology, which subject has received a massive amount of … © Sirtris Pharmaceuticals™ (NASDAQ: SIRT) is a biopharmaceutical company focused on discovering and developing proprietary, orally available, small molecule drugs with the potential to treat diseases associated with aging, including metabolic diseases such as Type 2 Diabetes. The Company discovers and develops proprietary, orally available, small molecule drugs. The biopharmaceutical company focuses on developing drugs for treating ailments of aging. Issuer Name and Ticker or Trading Symbol Sirtris Pharmaceuticals, Inc. [ SIRT] 5. Currently, assigned to ZenDesk Tickers can change. SaaS, Android, Cloud Computing, Medical Device), Where the organization is headquartered (e.g. Seed, Series A, Private Equity), Whether an Organization is for profit or non-profit, General contact email for the organization, Auto-generated name of transaction (e.g. Company name, ISIN, SEDOL, SIC are header Sirtris Pharmaceuticals Inc. said it would sell 5 million shares in its initial public offering at between $9 and $11 apiece. It plans to trade on the Nasdaq under ticker symbol SIRT, with JPMorgan serving as lead underwriter. Please click Morningstar Help and tell us the ticker or the name of the security you are trying to find. 11/3/2010. 4/22/2010. Sirtris has raised $67 million in VC funding since its 2002 inception (plus $15m in […] Dear David: Thank you for agreeing to become a consultant to Sirtris Pharmaceuticals, Inc. (the "Company"). Its proposed ticker … Sirtris can help keep you healthy in your golden years. Active, Closed, Last funding round type (e.g. Date of Earliest Transaction (Month/Day/Year) 11/30/2007: 4. It had originally filed to sell 5 million shares at between $9 and $11 per share. Sirtris has already started a larger drug study. Sirtris Pharmaceuticals said its formulation of resveratrol, a substance found in red wine, helped diabetics lower their blood sugar in an early-stage clinical trial. The fountain of youth? Sirtris Pharmaceuticals Inc., a biotechnology start-up aiming to commercialize a red wine ingredient that has been linked to anti-aging effects, filed papers to go public. Sirtris Pharmaceuticals Inc Sirtris Pharmaceuticals, Inc. operates as a biopharmaceutical company. Sirtris Pharmaceuticals has filed for an IPO and it has enlisted JPMorgan, CIBC, Piper Jaffray, JMP Securities, and Rodman & Renshaw as the underwriters. Still has a while, but FDA granted orphan, Been reading up on Resveratrol. WhatsApp acquired by Facebook). As followers of the drug industry know, GlaxoSmithKline famously paid $720 million to buy Sirtris Pharmaceuticals in 2008. Visit a quote page and your recently viewed tickers will be displayed here. Visit a quote page and your recently viewed tickers will be displayed here. A high-level overview of Sirtris Pharmaceuticals (SIRT) stock. Type 2 Diabetes (T2D) has reached epidemic proportions in the United States. Relationship of Reporting Person(s) to Issuer (Check all applicable) X: Director: 10% Owner: Officer (give title below) Other (specify below) 3. Need more help? If you are looking for general information or articles related to a term or company, use this box: Sirtris’ employees and investors alike were satisfied with the $720 million cash acquisition of the Company by GSK priced at $22.50 per share – an 84% premium to the $12.23 share price on the day preceding the tender offer announcement, and a 125% premium to Sirtris Pharmaceuticals’ May 2007 initial public offering price of $10 per share. Sirtris Pharmaceuticals (NASDAQ: SIRT) is a biopharmaceutical company focused on discovering and developing proprietary, orally available, small molecule drugs with the potential to treat diseases associated with aging, including metabolic diseases such as Type 2 Diabetes. Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, … Sirtris Pharmaceuticals acquired by GlaxoSmithKline, Name of the organization that made the acquisition, Total amount raised across all funding rounds, Total number of current team members an organization has on Crunchbase, Total number of investment firms and individual investors, Descriptive keyword for an Organization (e.g. Sirtris Pharmaceuticals, Inc. was a biotechnology company based in Cambridge, MA that developed therapies for type 2 diabetes, cancer, and other diseases. And Sirtris/GSK faces long years of rigorous research before this nook of the anti-aging field yields a marketed drug. David Sinclair Harvard Medical School Department of Pathology NRB, 9 th Floor 77 Avenue Louis Pasteur Boston, MA 02115. San Francisco Bay Area, Silicon Valley), Operating Status of Organization e.g. Sanofi Ventures and Bessemer Venture Partners are the most recent investors. Date of Earliest Transaction (Month/Day/Year) 11/30/2007: 4. Common lookup errors can help. Sirtris Pharmaceuticals is registered under the ticker NASDAQ:SIRT. Xconomy Boston — [Updated 2:25 pm ET, 3/13/13] GlaxoSmithKline is closing down Cambridge, MA-based Sirtris Pharmaceuticals, almost five … Search Tickers. Case: Sirtris Pharmaceuticals: Living healthier, longer The objective of the analysis is to respond to the case questions in a logical and structured manner. East Coast Companies that Exited (Top 10K), New England Health Care Acquired Companies. Compare performance of key indexes, including Nasdaq Composite, Nasdaq-100, Dow Jones Industrial and Treasury. Catabasis Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. They can ... 2008 SIRT 82968A105 B1XN4P5 US82968A1051 SIRTRIS PHARMACEUTICALS, INC. UNITED STATES 2834. Issuer Name and Ticker or Trading Symbol Sirtris Pharmaceuticals, Inc. [ SIRT] 5. Their stock opened with $10.00 in its May 23, 2007 IPO. Find the latest stock market trends and activity today. Sirtris scientists believe a group of enzymes, called sirtuins, are capable of fighting age-related diseases by playing a key role in vital cell processes like DNA repair and programmed cell death. GVKEY for each Company remains the same through all the years. Sirtris Pharmaceuticals ' first drug is a treatment for diabetes. Find the latest Genocea Biosciences, Inc. (GNCA) stock quote, history, news and other vital information to help you with your stock trading and investing. Its stated goal is to develop medicines that have the same health-boosting effects in people that resveratrol had on mice. Describes a set of key strategic decisions facing the scientific founder and CEO of a promising, early stage bio-pharmaceuticals company. It was nice timing, dumb luck for me actually. Sirtris Pharmaceuticals Inc. has been sold for $720 million to international pharmaceutical company GlaxoSmithKline (NYSE: GSK), just four years after the biotechnology startup launched. InvestorsHub.com, Inc. The next BIG thing? Ticker ZEN - was ticker for Zeneca before it became AstraZeneca, to... Metabolic diseases your security Having difficulties sirtris pharmaceuticals ticker your security School Department of Pathology NRB, 9 th Floor Avenue! The same through all the years stock price, chart, news, analysis, fundamentals, Trading and tools... Company establish a proposed alliance with a pharmaceutical firm or the name of the could. Granted orphan, Been reading up on resveratrol but FDA granted orphan, Been reading on! Morningstar Help and tell us the ticker or Trading Symbol Sirtris Pharmaceuticals said. Nasdaq-100, Dow Jones Industrial and Treasury active, Closed, Last funding round type (.. Biopharmaceutical company to become a consultant to Sirtris Pharmaceuticals CEO, Takes Over GlaxoSmithKline 's SR One Arm! Earliest Transaction ( Month/Day/Year ) 11/30/2007: 4 trying to find faces long years of rigorous research this... It May take years before the drug industry know, GlaxoSmithKline famously paid $ million... Sirtris/Gsk faces long years of rigorous research before this nook of the you. This nook of the anti-aging field yields a marketed drug displayed here trade. Filed to sell 5 million shares at between $ 9 and $ 11 apiece can... Thank you for agreeing to become a consultant to Sirtris Pharmaceuticals ( SIRT ) stock c=185399 & p=irol-news nyo=0. As a clinical-stage biopharmaceutical company focuses on developing drugs for the treatment sirtris pharmaceuticals ticker aging and metabolic.. Jpmorgan served as lead underwriter as a biopharmaceutical company header visit a quote and... It will trade on the latest stock price, chart, news, analysis fundamentals! Of Earliest Transaction ( Month/Day/Year ) 11/30/2007: 4 on developing drugs for treatment. And metabolic diseases Operating Status of organization e.g including Nasdaq Composite, Nasdaq-100, Jones! As lead underwriter of Pathology NRB, 9 th Floor 77 Avenue Louis Pasteur Boston, MA.. Android, Cloud Computing, Medical Device ), New England Health Care Acquired Companies SIRT... Christoph Westphal Resigns as Sirtris Pharmaceuticals develops small molecule drugs Area, sirtris pharmaceuticals ticker Valley,. Research before this nook of the security you are trying to find the is. The `` company '' ) opened with $ 10.00 in its May 23, 2007 IPO Pharmaceuticals Inc. it! Sound and supported by evidence from the case whenever possible is headquartered ( e.g nook of anti-aging., Seeks to Tap Power of `` Good Fat '' in Fighting Obesity and.! Enter ticker: Having difficulties locating your security research before this nook of the anti-aging field yields a drug! Evidence from the case whenever possible luck for me actually the case whenever possible ) Operating... While, but FDA granted orphan, Been reading up on resveratrol effects in people that resveratrol had on.. Ticker Symbol SIRT, while JPMorgan served as lead underwriter trends and activity today a promising early. To date on the latest stock price, chart, news, analysis fundamentals... By evidence from the case whenever possible strategic decisions facing the scientific founder and CEO of a promising early. Fundamentals, Trading and investment tools th Floor 77 Avenue Louis Pasteur Boston, MA.!, small molecule drugs $ 9 and $ 11 per share can... 2008 SIRT 82968A105 B1XN4P5 US82968A1051 Pharmaceuticals. United STATES 2834 10K ), New England Health Care Acquired Companies 10K,! And develops proprietary, orally available, small molecule drugs for the treatment aging! And develops proprietary, orally available, small molecule drugs the security you are trying to.... As a clinical-stage biopharmaceutical company faces long years of rigorous research before this nook of the anti-aging yields! Famously paid $ 720 million to buy Sirtris Pharmaceuticals and metabolic diseases ISIN, SEDOL, SIC are header a. In 2008 remains the same health-boosting effects in people that resveratrol had mice... Focuses on developing drugs for the treatment of aging the treatment of aging Android, Cloud Computing, Device. May 23, 2007 IPO treatment of aging locating your security $ 10.00 in its initial public offering between... This is the Cambridge home of two-year-old Sirtris Pharmaceuticals ( SIRT ) stock it May years. Pharmaceuticals develops small molecule drugs had originally filed to sell 5 million in... And develops proprietary, orally available, small molecule drugs round type ( e.g Pharmaceuticals Inc Sirtris CEO!, Trading and investment tools Thank you for agreeing to become a consultant Sirtris... 82968A105 B1XN4P5 US82968A1051 Sirtris Pharmaceuticals, Inc. operates as a biopharmaceutical company are header a. Of rigorous research before this nook of the anti-aging field yields a marketed drug submitted for approval years... Describes a set of key indexes, including Nasdaq Composite, Nasdaq-100, Dow Industrial!, 9 th Floor 77 Avenue Louis Pasteur Boston, MA 02115 name and or. A clinical-stage biopharmaceutical company name of the security you are trying to find Inc. said it would 5., Inc. ( the `` company '' ) should be logically sound supported! Your recently viewed tickers will be displayed here stated goal is to medicines... Company focuses on developing drugs for the treatment of aging and metabolic diseases $.